Overview

Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System Compared to Placebo in Children & Adolescents With ADHD

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

This study will evaluate safety and efficacy of d-Amphetamine Transdermal System for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents.

Phase:

Phase 2

Details

Lead Sponsor:

Noven Pharmaceuticals, Inc.

Treatments:

Amphetamine
Dextroamphetamine